{"id":"https://openalex.org/W1982967225","doi":"https://doi.org/10.1097/00005344-198609002-00028","title":"Substance P in Human Essential Hypertension","display_name":"Substance P in Human Essential Hypertension","publication_year":1986,"publication_date":"1986-09-01","ids":{"openalex":"https://openalex.org/W1982967225","doi":"https://doi.org/10.1097/00005344-198609002-00028","mag":"1982967225","pmid":"https://pubmed.ncbi.nlm.nih.gov/2455174"},"language":"en","primary_location":{"id":"doi:10.1097/00005344-198609002-00028","doi":"https://doi.org/10.1097/00005344-198609002-00028","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-198609002-00028","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113981105","display_name":"Hans\u2010Dieter Faulhaber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127591","display_name":"German Centre for Cardiovascular Research","ror":"https://ror.org/031t5w623","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210127591","https://openalex.org/I4405256427"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H. D. Faulhaber","raw_affiliation_strings":["Central Institute for Cardiovascular Research, Academy of Sciences of the G.D.R., Berlin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Institute for Cardiovascular Research, Academy of Sciences of the G.D.R., Berlin","institution_ids":["https://openalex.org/I4210127591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060649972","display_name":"PETER OEHME","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Oehme","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086034808","display_name":"R Baumann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Baumann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040923033","display_name":"J. Enderlein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Enderlein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033710985","display_name":"Ragna Rathsack","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Rathsack","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060803159","display_name":"G Rostock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Rostock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089704213","display_name":"Erna Naumann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Naumann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"10","issue":null,"first_page":"S172","last_page":"S176"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.28859999775886536,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.043800000101327896,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/substance-p","display_name":"substance P","score":0.996999979019165},{"id":"https://openalex.org/keywords/essential-hypertension","display_name":"essential hypertension","score":0.984000027179718},{"id":"https://openalex.org/keywords/psychological-stress","display_name":"psychological stress","score":0.828000009059906},{"id":"https://openalex.org/keywords/plasma-norepinephrine","display_name":"plasma norepinephrine","score":0.8659999966621399},{"id":"https://openalex.org/keywords/adrenergic-system","display_name":"adrenergic system","score":0.9470000267028809},{"id":"https://openalex.org/keywords/prazosin","display_name":"prazosin","score":0.9169999957084656},{"id":"https://openalex.org/keywords/captopril","display_name":"captopril","score":1.0},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/stress-sensitivity","display_name":"stress sensitivity","score":0.6380000114440918},{"id":"https://openalex.org/keywords/blood-pressure-regulation","display_name":"blood pressure regulation","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C2779479957","wikidata":"https://www.wikidata.org/wiki/Q421119","display_name":"Captopril","level":3,"score":0.8332513570785522},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7376532554626465},{"id":"https://openalex.org/C2780648677","wikidata":"https://www.wikidata.org/wiki/Q425296","display_name":"Prazosin","level":4,"score":0.7202487587928772},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7060279846191406},{"id":"https://openalex.org/C2777097880","wikidata":"https://www.wikidata.org/wiki/Q988405","display_name":"Essential hypertension","level":3,"score":0.6933578252792358},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6346498727798462},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.618159294128418},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.6092637777328491},{"id":"https://openalex.org/C2776533406","wikidata":"https://www.wikidata.org/wiki/Q187215","display_name":"Sympathetic nervous system","level":3,"score":0.4871801733970642},{"id":"https://openalex.org/C158453852","wikidata":"https://www.wikidata.org/wiki/Q4684738","display_name":"Adrenergic","level":3,"score":0.4587460160255432},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11211967468261719},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.10817191004753113}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002216","descriptor_name":"Captopril","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011224","descriptor_name":"Prazosin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013315","descriptor_name":"Stress, Psychological","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013373","descriptor_name":"Substance P","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00005344-198609002-00028","doi":"https://doi.org/10.1097/00005344-198609002-00028","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-198609002-00028","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:2455174","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2455174","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2433822134","https://openalex.org/W2405415148","https://openalex.org/W2412637789","https://openalex.org/W2417532168","https://openalex.org/W2411504053","https://openalex.org/W2472264572","https://openalex.org/W2169990949","https://openalex.org/W2336145363","https://openalex.org/W2475125526","https://openalex.org/W2094999820"],"abstract_inverted_index":{"Substance":[0],"P":[1],"(SP)":[2],"plays":[3],"an":[4,204],"important":[5],"role":[6],"in":[7,31,65,86,104,125,154,167,181,218,225,242],"central":[8],"nervous":[9],"and":[10,24,45,97,156,174,224,231],"peripheral":[11],"blood":[12],"pressure":[13],"regulation.":[14],"Its":[15],"effects":[16],"include":[17],"modulating":[18],"influence":[19,76],"on":[20,82],"the":[21,47,75,164,170,182,214,219,238],"adrenergic":[22,171],"system":[23],"inhibition":[25],"of":[26,77,130,151,177,206,216,221,234],"stress-induced":[27],"plasma":[28,107,152,178,207,229],"noradrenaline":[29,179],"increase":[30,176,205],"animal":[32],"studies.":[33],"In":[34],"patients":[35,87,127],"with":[36,88,99,169,189,197],"essential":[37,89],"hypertension":[38,90,223],"(n":[39,91],"=":[40,92,194,202],"45,":[41],"WHO":[42,94],"stages":[43],"1":[44],"2)":[46],"SP-like":[48],"immunoreactivity":[49],"(SPLIR)":[50],"was":[51,84,145,209],"found":[52],"significantly":[53,148],"(p":[54],"less":[55],"than":[56,64],"0.01)":[57],"lower":[58,133],"(1.36":[59],"+/-":[60,70,117,121,137,141],"0.23":[61],"pg/100":[62,72,123,143],"microliters)":[63,144],"24":[66],"normotensive":[67,101,105,155],"subjects":[68,106,158],"(4.54":[69],"0.72":[71],"microliters).":[73],"Furthermore,":[74],"a":[78,111,128],"mental":[79,113,160],"stress":[80,161,240],"test":[81,115],"SPLIR":[83],"investigated":[85],"11,":[93],"stage":[95],"1)":[96],"compared":[98],"nine":[100],"subjects.":[102],"Whereas":[103],"SP":[108,131,153,208,217,235],"increased":[109],"under":[110,159],"standardized":[112],"arithmetic":[114],"(4.03":[116],"0.48":[118],"to":[119,139],"4.74":[120],"0.56":[122],"microliters),":[124],"hypertensive":[126,157,183],"decrease":[129],"from":[132],"baseline":[134],"levels":[135,230],"(2.85":[136],"0.54":[138,142],"2.57":[140],"demonstrated.":[146],"The":[147,211],"different":[149],"changes":[150],"conditions":[162],"had":[163],"opposite":[165],"direction":[166],"comparison":[168],"reaction":[172],"[higher":[173],"prolonged":[175],"(NA)":[180],"group].":[184],"Under":[185],"antihypertensive":[186],"drug":[187],"treatment":[188],"prazosin":[190],"(4.5":[191],"mg/day,":[192,200],"n":[193,201],"10)":[195,203],"or":[196],"captopril":[198],"(450":[199],"registered.":[210],"results":[212],"support":[213],"participation":[215],"pathogenesis":[220],"human":[222],"therapeutic":[226],"mechanisms.":[227],"Lower":[228],"decreased":[232],"responsiveness":[233],"possibly":[236],"represent":[237],"enhanced":[239],"sensitivity":[241],"primary":[243],"hypertension.":[244]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}